Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1085088

High-throughput Virtual Screening Web Service Development for SARS-CoV-2 Drug Design


Miletić, Vedran; Ašenbrener Katić, Martina; Svedružić, Željko
High-throughput Virtual Screening Web Service Development for SARS-CoV-2 Drug Design // Proceedings of the 43rd International Convention MIPRO 2020, 1 (2020), 389-394 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1085088 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
High-throughput Virtual Screening Web Service Development for SARS-CoV-2 Drug Design

Autori
Miletić, Vedran ; Ašenbrener Katić, Martina ; Svedružić, Željko

Izvornik
Proceedings of the 43rd International Convention MIPRO 2020 (1847-3938) 1 (2020); 389-394

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
database modeling ; high-throughput virtual screening ; molecular dynamics ; high performance computing

Sažetak
The available structures of viral proteins and RNA molecules related to SARS-CoV-2 are used to screen and design a new set of drugs using the commercial databases and molecular docking protocols. The selected molecules are then studied further using molecular dynamics. Based on our earlier experiences we can target proteases, enzymes in DNA and RNA metabolism, and protein—protein interactions. In this paper we describe the planned research and development efforts for efficient screening and design of new drugs. Prior to the screening campaign, we will develop new open-source computational infrastructure, with two major outcomes. A new database containing all commercially available small-molecule ligands will be developed. A docking server with a web-based user interface will be developed and interfaced with the compound database. The docking server will use the database for sourcing of the molecules for the high-throughput virtual screening. Our approach offers major advantages that can bypass the problems that have traditionally plagued the pharmaceutical industry: our protocols are faster, cheaper, versatile, and offer minimal risks. We are developing new drugs using commercial databases, which allows us to buy the lead compounds for affordable prices that can bypass expensive and slow organic synthesis protocols.

Izvorni jezik
Engleski

Znanstvena područja
Kemija, Biologija, Računarstvo, Informacijske i komunikacijske znanosti, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)



POVEZANOST RADA


Ustanove
Sveučilište u Rijeci - Odjel za informatiku,
Sveučilište u Rijeci - Odjel za biotehnologiju

Citiraj ovu publikaciju

Miletić, Vedran; Ašenbrener Katić, Martina; Svedružić, Željko
High-throughput Virtual Screening Web Service Development for SARS-CoV-2 Drug Design // Proceedings of the 43rd International Convention MIPRO 2020, 1 (2020), 389-394 (međunarodna recenzija, članak, znanstveni)
Miletić, V., Ašenbrener Katić, M. & Svedružić, Ž. (2020) High-throughput Virtual Screening Web Service Development for SARS-CoV-2 Drug Design. Proceedings of the 43rd International Convention MIPRO 2020, 1, 389-394.
@article{article, year = {2020}, pages = {389-394}, keywords = {database modeling, high-throughput virtual screening, molecular dynamics, high performance computing}, journal = {Proceedings of the 43rd International Convention MIPRO 2020}, volume = {1}, issn = {1847-3938}, title = {High-throughput Virtual Screening Web Service Development for SARS-CoV-2 Drug Design}, keyword = {database modeling, high-throughput virtual screening, molecular dynamics, high performance computing} }




Contrast
Increase Font
Decrease Font
Dyslexic Font